menu
    • menu

    Company profile for AbCellera

    NEW Drugs in Dev: 6
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At AbCellera, team is everything. It is our brand, our product, and our culture. When great people share a vision and work together they truly can change the world. That’s why we hire for character and intelligence, not for CVs or experience. We look for people with drive and energy. Idealists. People we love and people we trust. This may be unconventional, but it is the key to our success. We understand that being valuable ...
    At AbCellera, team is everything. It is our brand, our product, and our culture. When great people share a vision and work together they truly can change the world. That’s why we hire for character and intelligence, not for CVs or experience. We look for people with drive and energy. Idealists. People we love and people we trust. This may be unconventional, but it is the key to our success. We understand that being valuable simply means helping others. That we amplify our impact by solving tough problems for our partners. This isn’t just about having the best technology, it comes from building a world-class team of innovators.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AbCelleraCanada Flag
    Country
    Country
    Canada
    Address
    Address
    2215 Yukon Street Vancouver, BC V5Y 0A1
    Telephone
    Telephone
    604.559.9005
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.abcellera.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/abcellera/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/abcellerabio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    MAGHREB Pharma Expo

    MAGHREB Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    MAGHREB Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abcellera To Present ABCL635 Phase 1 Clinical Data In Q1 2026
    Abcellera To Present ABCL635 Phase 1 Clinical Data In Q1 2026

    20 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-20/abcellera-to-highlight-phase-1-clinical-data-for-abcl635-during-upcoming-first-quarter-2026-earnings

    PHARMIWEB
    20 Apr 2026
    Share Share
    Abcellera To Release Q1 2026 Financial Results On May 11
    Abcellera To Release Q1 2026 Financial Results On May 11

    01 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-01/abcellera-to-report-first-quarter-2026-financial-results-on-may-11-2026

    PHARMIWEB
    01 Apr 2026
    Share Share
    Abcellera Reports Full Year 2025 Business Results
    Abcellera Reports Full Year 2025 Business Results

    24 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260224767346/en/AbCellera-Reports-Full-Year-2025-Business-Results

    BUSINESSWIRE
    24 Feb 2026
    Share Share
    Abcellera To Present At Investor Conferences In March-April 2026
    Abcellera To Present At Investor Conferences In March-April 2026

    11 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260210650979/en/AbCellera-to-Present-at-Upcoming-Investor-Conferences-in-March-and-April-2026

    BUSINESSWIRE
    11 Feb 2026
    Share Share
    Abcellera To Release 2025 Financial Results On Feb 24, 2026
    Abcellera To Release 2025 Financial Results On Feb 24, 2026

    22 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260122259748/en/AbCellera-to-Report-Full-Year-2025-Financial-Results-on-February-24-2026

    BUSINESSWIRE
    22 Jan 2026
    Share Share
    AbCellera Launches Phase 2 ABCL635 Trial for Menopause Symptoms
    AbCellera Launches Phase 2 ABCL635 Trial for Menopause Symptoms

    12 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260112396118/en/AbCellera-Announces-First-Patients-Dosed-in-Phase-2-Portion-of-its-Phase-12-Clinical-Trial-of-ABCL635-for-the-Treatment-of-Vasomotor-Symptoms-Due-to-Menopause

    BUSINESSWIRE
    12 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search